Janux Therapeutics Inc (JANX)
Healthcare
Biotechnology
15.20 $
-2.6%
vs. previous close
Closing price · As of: 31. Jul 2026
Janux Therapeutics Inc (JANX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -12 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -15 | -12 | -9.9 | -15 | -10 | -2.2 | -17 | -17 | -24 | -13 | -29 | -12 | -78 | |
| 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 2.0 | |
| 5.5 | 4.5 | 4.5 | 5.6 | 5.8 | 15 | 6.3 | 11 | 11 | 9.0 | 9.5 | 9.3 | 39 | |
| 3.7 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -1.7 | -3.1 | -1.1 | -4.4 | -7.4 | 13 | -0.3 | -0.5 | 3.8 | 6.5 | -3.1 | 4.9 | 12 | |
| 0.6 | 0.5 | 0.5 | 0.2 | 0.1 | 0.0 | 0.0 | 0.4 | 0.5 | 0.1 | 0.1 | 0.3 | 0.9 | |
| 18 | -61 | 11 | -114 | -191 | 13 | 34 | -340 | 1.6 | 8.3 | 30 | 8.3 | 48 | |
| – | – | – | – | – | – | – | -0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 0.5 | 57 | 0.8 | 322 | 2.8 | 1.6 | 387 | 0.6 | 1.0 | 0.5 | 2.9 | 3.5 | 7.9 | |
| 3.3 | -17 | 2.1 | 194 | -198 | 12 | 404 | -357 | -21 | -4.1 | 3.9 | -0.5 | -22 | |
| -16 | -12 | -10 | -15 | -10 | -2.3 | -17 | -17 | -24 | -13 | -29 | -13 | -78 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.